Kumiko Eguchi1, Tomohiko Shindo1, Kenta Ito1, Tsuyoshi Ogata1, Ryo Kurosawa1, Yuta Kagaya1, Yuto Monma1, Sadamitsu Ichijo1, Sachie Kasukabe1, Satoshi Miyata1, Takeo Yoshikawa2, Kazuhiko Yanai2, Hirofumi Taki3, Hiroshi Kanai4, Noriko Osumi5, Hiroaki Shimokawa6. 1. Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. 2. Department of Pharmacology, Tohoku University School of Medicine Sendai, Japan. 3. Biomedical Engineering for Health and Welfare, Graduate School of Biomedical Engineering, Tohoku University, Sendai, Japan. 4. Department of Electronic Engineering, Tohoku University Graduate School of Engineering, Sendai, Japan. 5. Department of Developmental Neuroscience, Tohoku University, Sendai, Japan. 6. Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: shimo@cardio.med.tohoku.ac.jp.
Abstract
BACKGROUND: Therapeutic focused-ultrasound to the hippocampus has been reported to exert neuroprotective effects on dementia. In the present study, we examined whether the whole-brain LIPUS (low-intensity pulsed ultrasound) therapy is effective and safe in 2 mouse models of dementia (vascular dementia, VaD and Alzheimer's disease, AD), and if so, to elucidate the common underlying mechanism(s) involved. METHODS: We used bilateral carotid artery stenosis (BCAS) model with micro-coils in male C57BL/6 mice as a VaD model and 5XFAD transgenic mice as an AD model. We applied the LIPUS therapy (1.875 MHz, 6.0 kHz, 32cycles) to the whole brain. RESULTS: In both models, the LIPUS therapy markedly ameliorated cognitive impairments (Y-maze test and/or passive avoidance test) associated with improved cerebral blood flow (CBF). Mechanistically, the LIPUS therapy significantly increased CD31-positive endothelial cells and Olig2-positive oligodendrocyte precursor cells (OPCs) in the VaD model, while it reduced Iba-1-positive microglias and amyloid-β (Aβ) plaque in the AD model. In both models, endothelium-related genes were significantly upregulated in RNA-sequencing, and expressions of endothelial nitric oxide synthase (eNOS) and neurotrophins were upregulated in Western blotting. Interestingly, the increases in glia cells and neurotrophin expressions showed significant correlations with eNOS expression. Importantly, these beneficial effects of LIPUS were absent in eNOS-knockout mice. CONCLUSIONS: These results indicate that the whole-brain LIPUS is an effective and non-invasive therapy for dementia by activating specific cells corresponding to each pathology, for which eNOS activation plays an important role as a common mechanism.
BACKGROUND: Therapeutic focused-ultrasound to the hippocampus has been reported to exert neuroprotective effects on dementia. In the present study, we examined whether the whole-brain LIPUS (low-intensity pulsed ultrasound) therapy is effective and safe in 2 mouse models of dementia (vascular dementia, VaD and Alzheimer's disease, AD), and if so, to elucidate the common underlying mechanism(s) involved. METHODS: We used bilateral carotid artery stenosis (BCAS) model with micro-coils in male C57BL/6 mice as a VaD model and 5XFAD transgenic mice as an AD model. We applied the LIPUS therapy (1.875 MHz, 6.0 kHz, 32cycles) to the whole brain. RESULTS: In both models, the LIPUS therapy markedly ameliorated cognitive impairments (Y-maze test and/or passive avoidance test) associated with improved cerebral blood flow (CBF). Mechanistically, the LIPUS therapy significantly increased CD31-positive endothelial cells and Olig2-positive oligodendrocyte precursor cells (OPCs) in the VaD model, while it reduced Iba-1-positive microglias and amyloid-β (Aβ) plaque in the AD model. In both models, endothelium-related genes were significantly upregulated in RNA-sequencing, and expressions of endothelial nitric oxide synthase (eNOS) and neurotrophins were upregulated in Western blotting. Interestingly, the increases in glia cells and neurotrophin expressions showed significant correlations with eNOS expression. Importantly, these beneficial effects of LIPUS were absent in eNOS-knockout mice. CONCLUSIONS: These results indicate that the whole-brain LIPUS is an effective and non-invasive therapy for dementia by activating specific cells corresponding to each pathology, for which eNOS activation plays an important role as a common mechanism.
Authors: M S Bobola; L Chen; C K Ezeokeke; T A Olmstead; C Nguyen; A Sahota; R G Williams; P D Mourad Journal: Brain Stimul Date: 2020-04-01 Impact factor: 8.955
Authors: Axel Montagne; Angeliki M Nikolakopoulou; Mikko T Huuskonen; Abhay P Sagare; Erica J Lawson; Divna Lazic; Sanket V Rege; Alexandra Grond; Edward Zuniga; Samuel R Barnes; Jacob Prince; Meghana Sagare; Ching-Ju Hsu; Mary J LaDu; Russell E Jacobs; Berislav V Zlokovic Journal: Nat Aging Date: 2021-06-14
Authors: Rodrigo Marmo da Costa E Souza; Inaê Carolline Silveira da Silva; Anna Beatriz Temoteo Delgado; Pedro Hugo Vieira da Silva; Victor Ribeiro Xavier Costa Journal: Dement Neuropsychol Date: 2018 Oct-Dec
Authors: Kaja Falkenhain; Nancy E Ruiz-Uribe; Mohammad Haft-Javaherian; Muhammad Ali; Pietro E Michelucci; Chris B Schaffer; Oliver Bracko Journal: PLoS One Date: 2020-08-28 Impact factor: 3.240